| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.02 | 0.7 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.02 | 0.7 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.021 | 0.7 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |